We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current AVNS market cap is 738.99M. The company's latest EPS is USD -1.3447 and P/E is -11.95.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 171.3M | 173.3M | 166.1M | 171.7M | 170.4M |
| Operating Income | 1.2M | -12.7M | 4M | 6.3M | 12M |
| Net Income | -3.7M | 10.5M | -900k | 1.8M | 9.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 697.6M | 714.8M | 744.6M | 824.3M | 673.3M |
| Operating Income | -55.7M | -46.1M | 8.9M | 74M | 4.2M |
| Net Income | -45.9M | -27.2M | 5.2M | 50.5M | -61.8M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.72B | 1.69B | 1.66B | 1.66B | 0 |
| Total Liabilities | 502.8M | 456.1M | 433.4M | 435.8M | 0 |
| Total Equity | 1.22B | 1.24B | 1.23B | 1.22B | 0 |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.8B | 1.67B | 1.59B | 1.79B | 1.69B |
| Total Liabilities | 534.4M | 416.3M | 330.7M | 495.7M | 456.1M |
| Total Equity | 1.27B | 1.26B | 1.26B | 1.29B | 1.24B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 19.7M | 32.4M | -8M | 19.8M | N/A |
| Investing | -59.4M | 21.6M | -2M | -7.9M | N/A |
| Financing | 20.5M | -94.2M | -700k | -5.7M | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -74.5M | -2.5M | 87.3M | 90.9M | 32.4M |
| Investing | -108.1M | -24.2M | -21M | -135.4M | 21.6M |
| Financing | 1.5M | -70M | -55.3M | 56.7M | -94.2M |
| Market Cap | 738.99M |
| Price to Earnings Ratio | -11.95 |
| Price to Sales Ratio | 1.1 |
| Price to Cash Ratio | 8.42 |
| Price to Book Ratio | 0.6 |
| Dividend Yield | - |
| Shares Outstanding | 45.96M |
| Average Volume (1 week) | 467.52k |
| Average Volume (1 Month) | 323.45k |
| 52 Week Change | -28.12% |
| 52 Week High | 25.36 |
| 52 Week Low | 16.02 |
| Spread (Intraday) | 4.36 (21.66%) |
| Company Name | Avanos Medical Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.avanos.com |
| Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
